NuVasive receives FDA 510(k) clearance for COHERE Porous PEEK implant

NuVasive announced it has received 510(k) clearance from the U.S. FDA for use of its COHERE Porous PEEK implant in eXtreme Lateral Interbody Fusion surgical spine procedures. COHERE XLIF is expected to launch commercially in the U.S. in second quarter 2019.
https://thefly.com/landingPageNews.php?id=2821089